GLP-1 Drugs and Liver Complications; Tracking Endoscopists’ Eyes; Peppermint for IBS
(MedPage Today) — GLP-1 receptor agonists and SGLT2 inhibitors were associated with lower risks for liver-related events and hepatocellular carcinoma (HCC) in type 2 diabetes patients compared with other glucose-lowering therapies, a systematic…
Kids Are Overdosing on GLP-1 Drugs, and It Can Get Dangerous Fast
Poison control calls involving GLP-1 medications like semaglutide and tirzepatide have dramatically risen in recent years.
There Are Many Types of Obesity, Says This GLP-1 Expert
A renowned physician-scientist says treatment is not one-size-fits-all.
Fractyl Health, Inc. (GUTS) Discusses REMAIN-1 Midpoint Cohort Results on Revita for Weight Maintenance After GLP-1 Discontinuation Transcript
GLP-1 lawsuits over side effects are growing
The complaints number over 4,400, a fraction of the more than 31 million people taking the weight-loss drugs
GLP-1 Receptor Agonists Tied to Lower Revision Rate After Functional Endoscopic Sinus Surgery
THURSDAY, Jan. 29, 2026 — Use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with reduced postoperative revision following functional endoscopic sinus surgery (FESS) for up to five years among patients with chronic…
STAT+: Lilly, Repertoire strike $2 billion autoimmune alliance
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello hello. Today, we learn more about AlphaGenome’s efforts to unravel DNA dark matter, read about a new AI-driven biotech backed by former Google CEO Eric Schmidt, and more. The need-to-know this morning: Sanofi and […]
Patients sue GLP-1 drugmakers, citing severe side effects | Morning in America
At least 3,000 patients have filed lawsuits against the companies behind GLP-1 weight loss drugs, alleging severe health risks, including blindness. NewsNation’s Brooke Shafer has the story on “Morning in America.” Start your day with “Morning in America,” NewsNation’s live three-hour national morning newscast hosted by Markie Martin. Weekdays starting at 6a/5C. #MorningInAmerica NewsNation is […]
Patients sue GLP-1 drugmakers, alleging severe side effects
Some patients have pointed to severe undisclosed side effects, including blindness, loss of brain function and organ damage.
GLP-1 drugs might do what food policy can’t — change the way we eat
The desire for smaller portions and fewer junk foods is affecting what the food industry is selling us.